|Articles|July 1, 2015

The Transition from Paper Records to Electonic Batch Records

Dennis Brandl, President, at BR&L Consulting, spoke with BioPharm International about what should be expected when transitioning from paper to EBR.

Dennis Brandl, President, at BR&L Consulting, spoke with BioPharm International about what should be expected when transitioning from paper to EBR.

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!

Related Content

High Angle Shot of a Working Desk of an Successful Person in Office with Cityscape Window View. | Image credit: © Gorodenkoff - stock.adobe.com

Analytics, Automation, and Quality Driving the Next Era of Drug Development

ByMike Hennessy Jr.

October 13th 2025

Therapeutic Nucleic Acids: Advanced Solutions for Downstream Processing & Analysis

ByTosoh Bioscience

October 13th 2025

pharmaceutical industrial washing and drying machine | Image Credit: ©Kadmy - stock.adobe.com

Considerations for Quality Improvement of Cleaning, Disinfection, and Cleaning Validation in Biopharmaceutical Manufacturing, Part II. Biopharmaceutical Non-Sterile Equipment Cleaning

ByThomas Altmann,Donald Singer,Stefan-Julian Frohberger

October 10th 2025

growth factor and stem cells | Image Credit: © Thongden_studio - stock.adobe.com

Reducing CAR-T Manufacturing Times and Cost: Q&A with Trenchant’s Jon Ellis

ByPatrick Lavery

October 9th 2025

Report - Digital Transformation in Biopharma: The Gap Between Hype and Implementation

ByChristopher Cole

October 9th 2025

The Transition from Paper Records to Electonic Batch Records

Newsletter

Related Content

Analytics, Automation, and Quality Driving the Next Era of Drug Development

Therapeutic Nucleic Acids: Advanced Solutions for Downstream Processing & Analysis

Considerations for Quality Improvement of Cleaning, Disinfection, and Cleaning Validation in Biopharmaceutical Manufacturing, Part II. Biopharmaceutical Non-Sterile Equipment Cleaning

Reducing CAR-T Manufacturing Times and Cost: Q&A with Trenchant’s Jon Ellis

Report - Digital Transformation in Biopharma: The Gap Between Hype and Implementation

Trending on BioPharm International

Rentschler’s Time Capsule and How it Symbolizes European Biotech Progress

Analytics, Automation, and Quality Driving the Next Era of Drug Development

Therapeutic Nucleic Acids: Advanced Solutions for Downstream Processing & Analysis